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Edited by Varda RotterAbstract Cell cycle progression in response to serum growth
factors is dependent on the expression of functional Hdm2
(Mdm2), which inhibits p53-dependent transcription of anti-pro-
liferative genes. In a well characterised non-transformed human
ﬁbroblast model, growth factors induce the expression of Hdm2
with rapid kinetics. Here we dissect the mechanistic basis for
this critical response. In contrast to previous studies in which
components of the growth factor signalling pathways were
overexpressed, hdm2 mRNA expression is not induced with
immediate-early kinetics in these cells. Rather, the elevated
Hdm2 protein levels which follow growth factor stimulation
are primarily a consequence of phosphatidylinositol-3 kinase-
dependent stabilisation of the Hdm2 protein combined with a
global increase in protein synthesis.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Growth factor1. Introduction
The transcription factor, p53, acts at a pivotal point of mul-
tiple stress–response pathways, and as such its activity in pro-
liferating cells must be tightly regulated in order to prevent
activation of a cell-cycle arrest or apoptotic response. The pri-
mary pathway whereby p53 function is restricted in unstressed
cells is via interaction with the Hdm2 oncoprotein (Mdm2 in
mouse) [1]. Hdm2 suppresses the transcriptional activation
function of p53, and also promotes its nuclear export and pro-
teosome-dependent destruction [2]. In absence of Hdm2 func-
tion, normal ﬁbroblast cells induce expression of the cdk
inhibitor, p21WAF1, and undergo a p53-dependent cell cycle
arrest [3], whereas in other cell-types, spontaneous apoptosis
may occur [4–6]. Hdm2/Mdm2 is itself a transcriptional target
of p53, as the gene has a promoter, P2, which contains p53
binding sites [7,8] and, in in vitro cultured mouse embryo ﬁbro-Abbreviations: PI3 kinase, phosphatidylinositol-3 kinase; Akt, v-akt
murine thymoma viral oncogene homologue kinase; MEK, mitogen-
activated protein kinase; ERK, extracellular-signal regulated kinase;
CDS, coding sequence; FCS, foetal calf serum
*Corresponding author. Fax: +44 (0)23 8079 5152.
E-mail address: j.p.blaydes@soton.ac.uk (J.P. Blaydes).
0014-5793/$32.00  2005 Federation of European Biochemical Societies. Pu
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dependent upon p53 [9]. A second promoter, P1, is constitu-
tively active, though the mdm2/hdm2-P1 mRNA transcript is
poorly translated [10].
Levels of Hdm2/Mdm2 protein are positively regulated by
growth factor signalling pathways that promote cell prolifera-
tion and survival [11,12]. Several distinct mechanisms underly-
ing this regulation have been demonstrated: Mosner et al. [11]
showed that the increased Mdm2 occurred in the absence of
any increase in total mdm2 mRNA on Northern blots, how-
ever expression of the mdm2 gene was subsequently shown to
be induced with immediate early kinetics in response to signal-
ling from chimeric platelet-derived growth factor b receptors
[13]. Experimental activation of one of the major growth factor
receptor tyrosine kinase-induced pathways, the Ras–Raf–
MEK–ERK kinase cascade, induces mdm2 P2-transcription
through activation of AP1 and ETS transcription factor bind-
ing to sites in the murine P2-promoter [14]. We have previously
shown that this pathway is at least partially conserved in
human cells [15,16], and Ras–Raf–MEK–ERK signalling also
selectively promotes the export of hdm2 mRNA from the
nucleus to sites of translation in the cytoplasm [16]. Ras–
Raf–MEK–ERK signalling is also known to regulate Hdm2
function through the increased transcription of the Hdm2-
binding protein p14ARF [17]. Finally, growth factor induced
activation of phosphatidylinositol-3 kinase (PI3 kinase)-v-akt
murine thymoma viral oncogene homologue kinase (Akt)/
PKB kinase signalling results in phosphorylation of Hdm2/
Mdm2, which increases the levels of the protein by reducing
its rate of proteosome-dependent degradation [18–20].
Given that these mechanisms have been the subject of inde-
pendent studies, it is diﬃcult to determine their relative contri-
bution to the levels in Hdm2 protein expression in any given
situation. To address this, we have taken a well deﬁned exper-
imental model, induction of Hdm2 expression immediately fol-
lowing serum re-stimulation of non-transformed human
ﬁbroblasts, and undertaken an investigation of the mecha-
nisms regulating Hdm2 protein levels in these cells.2. Methods
2.1. Cell culture, reagents, and cell cycle analysis
MRC-5 hTERT cells [21] were cultured in Dulbeccos modiﬁed Ea-
gles medium (Invitrogen) supplemented with 0.1% or 10% foetal calf
serum (FCS) (Autogen Bioclear). The following chemicals were added
where indicated: Nutlin-3 (Alexis Biochemicals), MG132 (Sigma),
cyclohexamide (Sigma), LY294002 (Calbiochem), U0126 (Promega).blished by Elsevier B.V. All rights reserved.
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fore DNA was stained with propidium iodide, and quantiﬁed using a
FACSCalibur ﬂow cytometer (BD Biosciences). Cells were transfected
using Lipofectamine 2000 reagent (Invitrogen).
2.2. mRNA and protein quantiﬁcation
Western blotting was performed as described previously [16] using
antibodies to Hdm2 (2A9 or 2A10 [22] (2A9 was used unless indicated
otherwise)), p53 (DO-1, Serotec), p21WAF-1 (Clone SX118, Pharmin-
gen), b-actin (Sigma), AKT, phospho-Ser-473 Akt, ERK1/ERK2
and phospho-Thr202r/Tyr204 ERK1/ERK2 (all from Cell Signalling
Technology). mRNA analysis, cell fractionation, polyribosome puriﬁ-
cation, RNA extraction, and validation of the fractionation by semi-
quantitative PCR for small cytoplasmic RNA Y4 were performed as
described previously [16]. cDNA synthesis and Taqman quantitative
PCR (qPCR) for hdm2-P1, hdm2-P2, hdm2-CDS and gapdh were per-
formed using previously described primers and probes [16]. hdm2
qPCR assays were performed in duplicate, and mean values norma-
lised to gapdh levels. n Values represent the number of individually
treated sets of cells analysed.3. Results
3.1. Hdm2 is required for cell-cycle progression in hTERT-
immortalised normal human ﬁbroblasts
MRC-5 hTERT is an immortal cell line that has been de-
rived by retroviral transduction of MRC-5, a well character-
ised human ﬁbroblast strain, with a vector expressing the
hTERT component of telomerase [21]. Previous work has
shown that serum stimulation of growth arrested MRC-5 cells
induces a rapid, and robust accumulation of Hdm2 protein
[19]. We therefore ﬁrst established whether MRC-5 hTERT
cells retain normal dependence upon serum growth factors
and Hdm2 function for cell cycle progression. Culture of
sub-conﬂuent MRC-5 hTERT cells for 24 h in 0.1% serum re-
sults in the expected accumulation of cells with a G1 DNA con-
tent (Fig. 1A). Re-stimulation with 10% serum results in cell
cycle re-entry and DNA replication after 6–24 h culture. How-
ever, if Nutlin-3, a pharmacological inhibitor of the Hdm2:p53
interaction [6], is added to the medium, G1 exit is blocked, con-
ﬁrming that these cells remain dependent on Hdm2 function.
Serum starvation resulted in reduced Hdm2 protein levels
compared to asynchronous, cells (Fig. 1B). Following serum
re-stimulation, Hdm2 protein levels increased rapidly, within
30 min of stimulation. Hdm2 detectable by the 2A9 monoclo-
nal antibody (upper panel) continued to increase from 30 minFig. 1. Role of Hdm2 in serum-stimulated cell-cycle re-entry. MRC-5 hTER
DMEM/10% FCS before analysis at the indicated time points. (A) Cellular D
iodide stained cells. Nutlin-3 (5 lM) was added to the DMEM/10% FCS wher
(top panel) and 2A10 monoclonal antibodies, which recognise diﬀerent epitop
observe the changes in Hdm2 protein levels.up to a peak at approximately 3 h post-stimulation, after
which it declined. This induction was conﬁrmed using an anti-
body to a diﬀerent epitope on Hdm2 (2A10). In comparison to
Hdm2, p21WAF-1 showed a more modest, and delayed, in-
crease, with an approximately 2-fold upregulation observable
at 3 h post-stimulation. During this time course, overall levels
of p53 remained essentially unchanged, potentially reﬂecting a
combined eﬀect of higher rates of synthesis with increased
Hdm2-dependent degradation.
3.2. Eﬀects of serum-stimulation on hdm2 mRNA synthesis,
nuclear export and translation
We next investigated whether the elevation of Hdm2 protein
levels following serum stimulation involves a selective increase
in hdm2-mRNA expression, using previously validated reverse
transcription – qPCR assays which are speciﬁc to each hdm2
transcript [16]. 1 h following serum stimulation there was no
signiﬁcant increase in either hdm2-P1 or hdm2-P2 transcript
levels in the cells, compared to the gapdh housekeeping mRNA
(Fig. 2Ai). A qPCR assay directed towards the hdm2 coding se-
quence (CDS) also showed no change. This contrasted to when
p53-dependent transcription in the cells was activated by Nut-
lin-3 (Fig. 2Aii), which caused an 11.7-fold increase in hdm2
P2-transcript levels, and a corresponding 5.2-fold increase in
total hdm2 CDS mRNA.
We therefore performed sub-cellular fractionation analysis
[16] to determine whether hdm2 mRNA is regulated at the
post-transcriptional level following serum-stimulation
(Fig. 2B). Within the 1 h timescale examined, there was no sig-
niﬁcant increase in the levels of hdm2 mRNA transcripts in the
cytoplasmic fraction, indicating that serum stimulation does
not lead to a selective enhancement of nuclear export of
hdm2 mRNA. Furthermore, when cytoplasmic extracts were
subjected to sucrose density centrifugation, there was no ser-
um-induced increase in hdm2 transcripts in the high molecular
weight-polyribosome associated fraction, indicating that rates
of hdm2 translation are not selectively increased.
3.3. Role of PI3 kinase – Akt-dependent Hdm2 protein
stabilisation
Fig. 3A shows that when proteosome-dependent degradation
of Hdm2 is inhibited using MG132, Hdm2 protein accumulates
as least as rapidly as is does following serum stimulation.
Therefore, Hdm2 protein is being actively synthesised in serumT cells were cultured for 24 h in DMEM/0.1% FCS, then refed with
NA content was determined by ﬂow cytometric analysis of propidium
e indicated. (B) Hdm2 was detected by western blotting using both 2A9
es. Exposure times for the individual blots were varied in order to best
Fig. 2. Eﬀect of serum stimulation on hdm2 mRNA expression,
localisation and translation. Hdm2 mRNA in MRC-5 hTERT cells
was analysed using RT-qPCR. hdm2-P1 (white bars) and hdm2-P2
(grey bars) transcripts, as well as hdm2-CDS containing mRNA (black
bars). (Ai) Cells were starved and refed as in Fig. 1A. Total RNA from
starved (0 h) and refed (1 h) cells was analysed. Data are means ±
S.E.M. for ﬁve individual experiments. (Aii) Asynchronous cells
growing in DMEM/10% FCS were exposed to 5 lM Nutlin-3 (N) or
carrier control (C) for 3 h before total RNA and protein was extracted
for RT-qPCR and western blot analysis. (B) Cells were cultured as in
(Ai). Prior to mRNA extraction, cells were fractionated by low salt
hypotonic lysis to produce a nuclear pellet, and soluble cytoplasmic
fraction (S). The cytoplasmic fraction was further fractionated to
isolate polyribosome associated mRNA (PA). Fractionations were
validated using semi-quantitative PCR for small cytoplasmic RNA Y4
and gapdh. Two diﬀerent amounts (3-fold dilution) of input cDNA
were used for each sample. The graphs show hdm2 levels at 1 h as a
percentage of those in starved cells, n = 2.
Fig. 3. PI3 kinase dependent Hdm2 stabilisation is suﬃcient to
account for the serum-induced Hdm2 induction. (A) Cells were
cultured in DMEM/0.1% FCS for 24 h then cells were refed with
medium containing 10% serum and/or 50 lM MG132. (B) Cells were
cultured in DMEM/0.1% FCS for 24 h then refed using medium
containing the indicated combinations of 10% serum, 50 lM MG132
and 10 lMLY294002. Akt activation by phosphorylation at serine 473
was determined following 45 min exposure of cells to 10% serum and
either 10 lM LY294002 or carrier control. (C) Cells in 100 mm culture
dishes were transfected for 24 h with 8 lg of the pCMV-mdm2
expression vector (encoding full length human Hdm2), before being
cultured in DMEM/0.1% FCS for 24 h. Cells were refed with medium
containing the indicated combination of serum and 10 lM LY294002
or carrier control for 45 min before 100 lg/ml cycloheximide (CHX)
was added to the medium to block new protein synthesis. Cells were
lysed at the time points indicated after cyclohexamide addition.
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theoretically cause the observed increase in Hdm2 protein
solely by reducing the rates of its degradation.
Treatment of MRC-5 hTERT cells with the PI3 kinase inhib-
itor, LY294002, blocked serum-induced activation of Akt
(Fig. 3B) and also eﬀectively blocked the serum induced in-
crease in Hdm2 protein levels (Fig. 3B, compare lanes 3 and
4), demonstrating that the increase in Hdm2 protein is PI3 ki-
nase dependent. Inhibition of PI3 kinase did not block the in-
crease in Hdm2 protein caused by the MG132 proteosome
inhibitor alone (not shown), and, more importantly, Hdm2
protein was still upregulated in the presence of 10% serum
and MG132 when LY294002 was added. Therefore,
LY294002 does not prevent Hdm2 protein synthesis in either
the absence or presence of serum growth factors. Together
these data suggest that the primary mechanism underlying
the selective upregulation of Hdm2 protein levels following
serum stimulation of human ﬁbroblasts is the well documented
PI3 kinase – Akt dependent enhancement of Hdm2 protein sta-
bility, with no evidence of any selective increase in hdm2mRNA synthesis, export or translation. This conclusion is sup-
ported by the analysis of Hdm2 protein stability in these cells
(Fig. 3C). Following blockade of protein synthesis by cyclo-
hexamide, Hdm2 protein falls to undetectable levels within
45 min in starved cells, whereas following serum stimulation
Hdm2 is still clearly detectable at this time point. In the pres-
ence of serum and LY294002, Hdm2 is degraded more rapidly
than in serum starved cells.
3.4. MEK activity is required for optimal Hdm2 protein
synthesis
The previous experiments do not exclude a role for Ras–
Raf–MEK–ERK signalling in optimal growth factor-induced
Hdm2 expression, and therefore we investigated the role of this
pathway. We found that, when the pharmacological mitogen-
activated protein kinase (MEK) inhibitor U0126 is added at
the time of serum re-stimulation, extracellular-signal regulated
kinase (ERK) activation is blocked and a modest, but repro-
ducible, decrease in Hdm2 protein levels is observed
(Fig. 4A). U0126 also causes a small reduction in the Hdm2
Fig. 4. MEK activity is required for optimal Hdm2 synthesis following
serum re-stimulation. Cells were cultured in DMEM/0.1% FCS for
24 h then treated as indicated. (A) Cells were refed with medium
containing 10% serum and/or 50 lM MG132 or 25 lM U0126 before
blotting for Hdm2. ERK phosphorylation was determined at 45 min
post-serum re-stimulation. (B) hdm2 coding sequence containing
mRNA was quantiﬁed in either total (TOT) or polyribosome associ-
ated (PA) RNA fractions from cells 45 min after refeeding. Levels are
shown relative to gapdh mRNA expression. Open bars = no serum,
grey bars = 10% serum, black bars = 10% serum + 25 lM U0126.
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rate of protein synthesis following MEK inhibition. This
reduction in Hdm2 synthesis did not occur due to any speciﬁc
eﬀects on hdm2 mRNA synthesis or translation, as U0126 did
not cause any decrease in hdm2 mRNA associated with polyri-
bosomes relative to gapdh mRNA (Fig. 4B). However, when
the amounts of RNA yielded from the diﬀerent fractions were
analysed, we observed a reduction in the proportion of the to-
tal cytoplasmic RNA that was associated with polyribosomes
from 42% in serum re-stimulated cells to 24% with U0126
treatment. This represents a 42% decrease in global translation
rates following MEK inhibition, and would account for the
U0126-induced reduction in Hdm2 protein levels compared
to the majority of other, more stable, cellular proteins.4. Discussion
Along with p53, Hdm2 lies at a point of integration of a
huge range of both intra- and extra-cellular stimuli, the ﬁne
balance of the activities of these two proteins playing a key role
in cell proliferation and survival [1]. Hdm2 itself can be regu-
lated at multiple points, both pre- and post-translational, even
in response to a single type of stimulus and it is often diﬃcult
to establish, in any given situation, which mechanisms are pri-
marily responsible for any observed changes in cellular Hdm2
activity. Here we have shown that, when phenotypically
normal human ﬁbroblast cells are stimulated to proliferateby serum growth factors, the rapid increase in Hdm2 protein
levels is primarily dependent upon activation of the PI3 kinase
– Akt/PKB signalling pathway, and resultant reduced rates of
proteosome-dependent degradation of the Hdm2 protein,
which is known to involve the direct phosphorylation of
Hdm2 by Akt/PKB [18–20].
A second major growth factor-induced kinase cascade Ras–
Raf–MEK–ERK is, as has previously been shown in diﬀerent
experimental systems by a number of groups including our
own [13,14,16], also required for optimal rates of Hdm2 syn-
thesis in these cells. However, this is not due to any selective
regulation of hdm2 mRNA expression or translation, but
rather reﬂects the known requirement for Ras–Raf–MEK–
ERK signalling for the global increase in mRNA translation
and protein synthesis in response to serum growth factors
[23,24]. It is interesting to consider why the previously de-
scribed mechanisms of speciﬁc MEK-dependent regulation of
Hdm2 synthesis are not observed in this system. We have
shown previously that incubation of breast cancer epithelial
cells with U0126 for 7–24 h results in the selective inhibition
of nuclear export of hdm2 mRNA [16], however serum stimu-
lation of ﬁbroblasts has no speciﬁc eﬀect on hdm2 mRNA ex-
port. Potentially therefore, hdm2 regulation at this level occurs
in some cell types, and not others, or alternatively the eﬀect
may only be observed following prolonged inhibition of
MEK activity. Other studies have shown murine mdm2 to be
induced by growth factors receptors and Ras–Raf–MEK–
ERK signalling, through immediate early type transcriptional
activation of the P2 promoter [13,14], Here we have shown
that this does not occur following serum stimulation of human
ﬁbroblasts. Whilst we have previously conﬁrmed that human
Hdm2-P2 transcription expression is positively inﬂuenced by
MEK activity in cancer cells [16], we have noted diﬀerences
in the transcription factor binding elements in the human
and murine P2-promoters which could result in the human
promoter being less responsive to this pathway [15]. Alterna-
tively, it may be relevant that previous reports [13,14] only di-
rectly demonstrated MEK-dependent regulation of P2
transcription when components of the signalling pathway were
either artiﬁcially overexpressed, or contained constitutive acti-
vating mutations, and therefore, overstimulation of the growth
factor receptor-Ras–Raf–MEK–ERK pathway may be re-
quired for Hdm2 P2 promoter activation to occur.
In the broader perspective, Hdm2 overexpression is associ-
ated with a wide number of malignancies and Hdm2 is a target
for a new class of small molecules with potential a cancer ther-
apeutics [6]. This study on the normal pathways of Hdm2 reg-
ulation highlights some of the multiplicity of mechanisms
whereby dysregulated intracellular signalling pathways might
result in Hdm2 overexpression in tumours.
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